Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-14

Clinical Trial Update: Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the pharmacokinetics of the Mefloquine-Artesunate combination for Plasmodium falciparum malaria in pregnancy. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)
  • Mefloquine (Mefloquine)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Plasmodium Falciparum Malaria | Phase 2, Phase 3 | Status: COMPLETED